- Home
- TLSI vs LODE Comparison
TLSI vs LODE Comparison
Compare TLSI & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | LODE |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 229.1M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | TLSI | LODE |
|---|---|---|
| Price | $4.00 | $3.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.00 | $4.00 |
| AVG Volume (30 Days) | 197.9K | ★ 1.1M |
| Earning Date | 03-05-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,553,796.00 |
| Revenue This Year | $36.47 | $1,429.67 |
| Revenue Next Year | $39.31 | $270.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.42 | $1.67 |
| 52 Week High | $7.95 | $4.80 |
Technical Indicators
Market Signals| Indicator | TLSI | LODE |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 49.39 |
| Support Level | $3.79 | $2.61 |
| Resistance Level | $5.33 | $3.43 |
| Average True Range (ATR) | 0.24 | 0.22 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 48.05 | 50.00 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.